These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

709 related items for PubMed ID: 10353939

  • 1. Growth, puberty, and endocrine functions in patients with sporadic or familial neurofibromatosis type 1: a longitudinal study.
    Carmi D, Shohat M, Metzker A, Dickerman Z.
    Pediatrics; 1999 Jun; 103(6 Pt 1):1257-62. PubMed ID: 10353939
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Height prognosis of children with true precocious puberty and growth hormone deficiency: effect of combination therapy with gonadotropin releasing hormone agonist and growth hormone.
    Cara JF, Kreiter ML, Rosenfield RL.
    J Pediatr; 1992 May; 120(5):709-15. PubMed ID: 1533661
    [Abstract] [Full Text] [Related]

  • 5. Growth, puberty and hypothalamic-pituitary function in children with suprasellar arachnoid cyst.
    Adan L, Bussières L, Dinand V, Zerah M, Pierre-Kahn A, Brauner R.
    Eur J Pediatr; 2000 May; 159(5):348-55. PubMed ID: 10834520
    [Abstract] [Full Text] [Related]

  • 6. Premature thelarche: identification of clinical and laboratory data for the diagnosis of precocious puberty.
    Della Manna T, Setian N, Damiani D, Kuperman H, Dichtchekenian V.
    Rev Hosp Clin Fac Med Sao Paulo; 2002 May; 57(2):49-54. PubMed ID: 11981584
    [Abstract] [Full Text] [Related]

  • 7. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J, Reynaud R, Czernichow P.
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Familial male-limited precocious puberty in neurofibromatosis type I.
    Lim YY, Chan RM, Loke KY, Ho CW, Lee YS.
    Eur J Pediatr; 2014 Feb; 173(2):219-22. PubMed ID: 23982246
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Adult height after cranial irradiation for optic pathway tumors: relationship with neurofibromatosis.
    Huguenin M, Trivin C, Zerah M, Doz F, Brugieres L, Brauner R.
    J Pediatr; 2003 Jun; 142(6):699-703. PubMed ID: 12838200
    [Abstract] [Full Text] [Related]

  • 16. Outcome of gonadotropin-releasing analog treatment for children with central precocious puberty: 15-year experience in southern Thailand.
    Jaruratanasirikul S, Thaiwong M.
    J Pediatr Endocrinol Metab; 2011 Jun; 24(7-8):519-23. PubMed ID: 21932591
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Precocious puberty in children with neurofibromatosis type 1.
    Habiby R, Silverman B, Listernick R, Charrow J.
    J Pediatr; 1995 Mar; 126(3):364-7. PubMed ID: 7869193
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.